Forum on Immunopathological Diseases and Therapeutics Impact Factor in Chemistry Journals

Forum on Immunopathological Diseases and Therapeutics in Chemistry Journals

Journal Country: United States
Journal Q tier: Q4
Publishing Firm: Begell House Inc.
History: 2010-2016, 2021
Journal Homepage: Not Available
Journal ISSN: 21518025, 21518017

Research Categories

Biochemistry (Q4); Biotechnology (Q4); Genetics (Q4); Molecular Medicine (Q4)

Impact Score: 0.11
h-Index: 14
SJR: 0.107
Ranking: 25656

About Forum on Immunopathological Diseases and Therapeutics

Forum on Immunopathological Diseases and Therapeutics is a journal covering the technologies/fields/categories related to Biochemistry (Q4); Biotechnology (Q4); Genetics (Q4); Molecular Medicine (Q4). It is published by Begell House Inc.. The overall rank of Forum on Immunopathological Diseases and Therapeutics is 25656.According to SCImago Journal Rank (SJR), this journal is ranked 0.107. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 14. The best quartile for this journal is Q4.The ISSN of Forum on Immunopathological Diseases and Therapeutics journal is 21518025, 21518017.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Forum on Immunopathological Diseases and Therapeutics is cited by a total of 1 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.